We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
-13.89%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$744M
AUM Growth
-$81.5M
Cap. Flow
+$46.5M
Cap. Flow %
6.24%
Top 10 Hldgs %
31.55%
Holding
2,869
New
240
Increased
1,414
Reduced
721
Closed
181

Sector Composition

Rank Sector Weight
1 Technology 12.36%
2 Healthcare 7.65%
3 Financials 6.69%
4 Consumer Staples 6.68%
5 Consumer Discretionary 5.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEX
2076
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$4K ﹤0.01%
385
ARNC
2077
DELISTED
Arconic Corporation
ARNC
$4K ﹤0.01%
137
+11
+9% +$297
TCDA
2078
DELISTED
Tricida, Inc. Common Stock
TCDA
$4K ﹤0.01%
+417
New +$3.97K
GTYH
2079
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$4K ﹤0.01%
+695
New +$3.55K
CTIC
2080
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$4K ﹤0.01%
+593
New +$3.04K
ABCB icon
2081
Ameris Bancorp
ABCB
$5.77B
$3K ﹤0.01%
87
-60
-41% -$2.54K
ACLS icon
2082
Axcelis
ACLS
$3.94B
$3K ﹤0.01%
63
+22
+54% +$1.27K
AMCX icon
2083
AMC Global Media
AMCX
$445M
$3K ﹤0.01%
102
-138
-58% -$4.87K
AMWD
2084
DELISTED
American Woodmark
AMWD
$3K ﹤0.01%
63
+4
+7% +$193
ANGO icon
2085
AngioDynamics
ANGO
$565M
$3K ﹤0.01%
147
ATNI icon
2086
ATN International
ATNI
$364M
$3K ﹤0.01%
57
-117
-67% -$4.95K
BBT
2087
Beacon Financial Corp
BBT
$2.48B
$3K ﹤0.01%
104
-1
-1% -$26
BPMC
2088
DELISTED
Blueprint Medicines
BPMC
$3K ﹤0.01%
69
+60
+667% +$3.52K
BRBR icon
2089
BellRing Brands
BRBR
$1.52B
$3K ﹤0.01%
105
-10
-9% -$245
CACC icon
2090
Credit Acceptance
CACC
$5.78B
$3K ﹤0.01%
6
CALM icon
2091
Cal-Maine
CALM
$4.2B
$3K ﹤0.01%
63
-174
-73% -$8.83K
CHCO icon
2092
City Holding Co
CHCO
$2.03B
$3K ﹤0.01%
34
CHGG icon
2093
Chegg
CHGG
$110M
$3K ﹤0.01%
147
-1,688
-92% -$38.7K
CLDT
2094
Chatham Lodging
CLDT
$643M
$3K ﹤0.01%
313
+3
+1% +$38
CRNC icon
2095
Cerence
CRNC
$375M
$3K ﹤0.01%
121
+35
+41% +$1.05K
CRSP icon
2096
CRISPR Therapeutics
CRSP
$4.6B
$3K ﹤0.01%
51
-111
-69% -$6.53K
CTO
2097
CTO Realty Growth
CTO
$744M
$3K ﹤0.01%
171
CVGW
2098
DELISTED
Calavo Growers
CVGW
$3K ﹤0.01%
69
-178
-72% -$6.45K
CVI icon
2099
CVR Energy
CVI
$3.43B
$3K ﹤0.01%
95
+53
+126% +$1.69K
DBX icon
2100
Dropbox
DBX
$7.13B
$3K ﹤0.01%
136
-128
-48% -$2.77K

Similar funds

Quadrant Capital Group's Q2 2022 Portfolio in Review

As of Q2 2022, Quadrant Capital Group held 2,869 positions worth $744M, down 9.9% from $826M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Quadrant Capital Group deployed $46.5M of net new capital in Q2 2022, opening 240 new positions and adding to 1,414 existing holdings. Its largest new stake was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $4.02M trimmed.

  • Quadrant Capital Group's largest Q2 2022 buy was Vanguard Intermediate-Term Bond ETF: 21,020 shares worth $1.63M.
  • Quadrant Capital Group added most to iShares Core MSCI EAFE ETF in Q2 2022, an estimated $7.4M increase.
  • Quadrant Capital Group's biggest Q2 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $4.02M.
  • Quadrant Capital Group fully exited RiverNorth Opportunistic Municipal Income Fund in Q2 2022, selling an estimated $900K.
  • Quadrant Capital Group's ten largest holdings make up 32% of its $744M portfolio in Q2 2022.
  • Quadrant Capital Group opened 240 new positions and closed 181 in Q2 2022.
  • Quadrant Capital Group's portfolio value fell 9.9% quarter-over-quarter to $744M.

Based on Quadrant Capital Group's 13F filing for Q2 2022, filed 9 Aug 2022.